{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:28:31Z","timestamp":1791325711654,"version":"4.3.1"},"reference-count":73,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2003,3,15]]},"abstract":"<jats:p> Adult granulosa cell tumor (GCT) of the ovary is oftentimes a hormonally active, stromal cell neoplasm that is distinguished by its ability to secrete sex steroids such as estrogen. Patients may present with vaginal bleeding caused by endometrial hyperplasia or uterine cancer as a result of prolonged exposure to tumor-derived estrogen. In addition, GCT is a vascular tumor that may occasionally rupture and result in abdominal pain, hemoperitoneum, and hypotension, mimicking an ectopic pregnancy in younger patients. GCT is usually associated with a mass on pelvic examination that is subsequently confirmed on ultrasonography. Surgery is required for definitive tissue diagnosis, staging, and tumor debulking. In older women, a total abdominal hysterectomy and bilateral salpingooophorectomy are typically performed. In women of childbearing age, a more conservative unilateral salpingo-oophorectomy may be performed, assuming that careful staging reveals that the disease has not extended outside of the involved ovary and that a concomitant uterine cancer has been excluded. Survival of patients with GCT is generally excellent because most patients present with early-stage disease, although certain high-risk patient groups may be identified. Stage is the most important prognostic factor, with a higher risk of relapse being associated with stages II through IV disease. In addition, patients with stage I disease associated with features such as large tumor size, high mitotic index, or tumor rupture may also be at higher risk in some series. The value of postoperative adjuvant therapy for high-risk patients has not been investigated by prospective randomized trials, which are difficult to perform because of the rarity of this tumor. Nonetheless, the use of adjuvant chemotherapy or radiation has sometimes been associated with prolonged disease-free survival in patients with high-risk features. Because of the propensity of GCT to recur years after initial diagnosis, prolonged surveillance with serial physical examination and serum tumor markers such as estradiol and inhibin is reasonable. <\/jats:p>","DOI":"10.1200\/jco.2003.10.019","type":"journal-article","created":{"date-parts":[[2003,3,13]],"date-time":"2003-03-13T17:44:34Z","timestamp":1047577474000},"page":"1180-1189","source":"Crossref","is-referenced-by-count":563,"title":["Granulosa Cell Tumor of the Ovary"],"prefix":"10.1200","volume":"21","author":[{"given":"Susan Tinsley","family":"Schumer","sequence":"first","affiliation":[{"name":"From the Program in Gynecologic Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Cannistra","sequence":"additional","affiliation":[{"name":"From the Program in Gynecologic Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-198408000-00002"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.3109\/15513818809041579"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1997.4695"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1993.1019"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197501)35:1<231::AID-CNCR2820350128>3.0.CO;2-O"},{"key":"R6","unstructured":"Pankratz E, Boyes DA, White GW, et al: Granulosa cell tumors: A clinical review of 61 cases. Obstet Gynecol 52:718,1978\u2013723,"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(79)90090-8"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(81)90040-8"},{"key":"R9","unstructured":"Evans AT, Gaffey TA, Malkasian GD, et al: Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol 55:231,1980\u2013238,"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(83)90083-5"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1994.1010"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930550203"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970515)79:10<1951::AID-CNCR16>3.0.CO;2-U"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/S0936-6555(98)80008-3"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91071-S"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199409223311204"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198703123161102"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(99)70207-3"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(71)90965-3"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503303321308"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Vesco KK, Carney ME: Granulosa cell tumor of the ovary: Extensive late recurrence after initial occult microscopic disease. Obstet Gynecol 99:888,2002\u2013891,","DOI":"10.1016\/S0029-7844(01)01665-9"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311183292108"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198909213211204"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196802)21:2<255::AID-CNCR2820210214>3.0.CO;2-5"},{"key":"R26","unstructured":"Giuntoli RL, Celebre JA, Wu CH, et al: Androgenic function of a granulosa cell tumor. Obstet Gynecol 47:77,1976\u201379,"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.172.5.10227493"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1148\/radiographics.16.1.200"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(76)90577-9"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.2001.801120.x"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2001.6183"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-200101000-00007"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(97)90229-X"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(86)90035-1"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(96)70333-2"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1996.4520"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1994.1291"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311183292104"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.3.4800"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00656.x"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(97)70090-5"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1998.5290"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195203)5:2<215::AID-CNCR2820050203>3.0.CO;2-O"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1996.0130"},{"key":"R46","unstructured":"Miller BE, Barron BA, Dockter ME, et al: Parameters of differentiation and proliferation in adult granulosa cell tumors of the ovary. Cancer Detect Prev 25:48,2001\u201354,"},{"key":"R47","unstructured":"Fletcher JA, Gibas Z, Donovan K, et al: Ovarian granulosa-stromal cell tumors are characterized by trisomy 12. Am J Pathol 138:515,1991\u2013520,"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-199510000-00006"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(98)00249-0"},{"key":"R50","doi-asserted-by":"publisher","DOI":"10.1097\/01.MP.0000024290.55261.14"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950501)75:9<2295::AID-CNCR2820750918>3.0.CO;2-C"},{"key":"R52","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1997.4803"},{"key":"R53","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.5774"},{"key":"R54","unstructured":"Malkasian G, Webb MJ, Jorgensen EO: Observations on chemotherapy of granulosa cell carcinomas and malignant ovarian teratomas. Obstet Gynecol 44:885,1974\u2013888,"},{"key":"R55","unstructured":"Disaia PJ, Saltz A, Kagan AR, et al: A temporary response of recurrent granulosa cell tumor to adriamycin. Obstet Gynecol 52:355,1978\u2013358,"},{"key":"R56","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197310)32:4<735::AID-CNCR2820320401>3.0.CO;2-K"},{"key":"R57","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950120608"},{"key":"R58","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-198602000-00020"},{"key":"R59","unstructured":"Gershenson DM, Copeland LJ, Kavanagh JJ, et al: Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin and cyclophosphamide. Obstet Gynecol 70:765,1987\u2013769,"},{"key":"R60","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(90)90133-6"},{"key":"R61","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(83)90589-6"},{"key":"R62","doi-asserted-by":"publisher","DOI":"10.1378\/chest.75.2.194"},{"key":"R63","unstructured":"Pecorelli S, Wagener P, Bonazzi G, et al: Cisplatin (P), vinblastine (V), and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa cell tumor of the ovary (GCTO): An EORTC Gynecologic Cancer Cooperative Group study. Proc Am Soc Clin Oncol 7:147,1988,  (abstr 567)"},{"key":"R64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706043162302"},{"key":"R65","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(95)00491-2"},{"key":"R66","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1998.5304"},{"key":"R67","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1438.1995.05020156.x"},{"key":"R68","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1998.5287"},{"key":"R69","unstructured":"Engle RB: Roentgen treatment of granulosa cell carcinoma of the ovary. AJR Am J Roentgenol 80:793,1958\u2013798,"},{"key":"R70","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1998.5338"},{"key":"R71","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1996.0078"},{"key":"R72","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(82)90102-0"},{"key":"R73","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(89)90089-9"},{"key":"R74","unstructured":"Fishman A, Kudelka A, P, Tresukosol D, et al: Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumor. J Reprod Med 41:393,1996\u2013396,"},{"key":"R75","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008218720561"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2003.10.019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T20:35:05Z","timestamp":1653510905000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2003.10.019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,15]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,3,15]]}},"alternative-id":["10.1200\/JCO.2003.10.019"],"URL":"https:\/\/doi.org\/10.1200\/jco.2003.10.019","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,15]]}}}